Colgate-Palmolive (CL) is back in focus after two senior leadership moves, with Samir Singh taking over the global oral care business and longtime executive Ram Raghavan stepping into the Chief Marketing Officer role.

At a share price of US$85.10, Colgate-Palmolive has seen short term share price pressure, with the 7 day return down 7.16% and the 90 day share price return down 9.04%. However, the year to date share price return of 9.54% and 3 year total shareholder return of 20.63% point to momentum built over a longer horizon as investors weigh the leadership changes and earlier earnings beats against valuation sensitivities.

If this kind of brand led story has your attention, it can be useful to broaden the watchlist and scan other consumer focused leaders via the 21 top founder-led companies

With Colgate-Palmolive shares trading at US$85.10 and sitting at a discount to both analyst targets and some fair value estimates, the key question is simple: are you looking at a genuine value gap or is the market already pricing in future growth?

Most Popular Narrative: 12% Undervalued

Colgate-Palmolive's most followed narrative pegs fair value at about $96.68 per share, compared with the last close at $85.10, which frames a sizeable valuation gap for investors to interrogate.

Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll out of complementary products across 75 markets, are set to capture increased value from emerging middle class consumers and rising health/hygiene awareness globally, supporting top line organic sales acceleration and improved pricing power.

Curious how this growth story translates into that fair value number? The narrative leans on steady revenue expansion, rising margins, and a future earnings multiple that assumes Colgate-Palmolive keeps compounding its brand strength. The real surprise is how tightly those pieces have to fit together for $96.68 to make sense.

Result: Fair Value of $96.68 (UNDERVALUED)

However, the narrative also leans on cost relief and steady demand, so prolonged input inflation or weaker volumes in markets like North America or India could quickly challenge it.

Another View: Earnings Multiple Tells A Different Story

The narrative suggests Colgate-Palmolive is about 12% undervalued on fair value, yet the current P/E of 32.6x is well above the estimated fair ratio of 21.6x, above peers at 20.8x, and above the global Household Products average at 16.6x. That premium points to valuation risk rather than a clear bargain, so which signal do you put more weight on?

Next Steps

If this mix of optimism and concern around Colgate-Palmolive resonates with you, now is a good time to review the data and form your own stance by weighing the 3 key rewards and 3 important warning signs

Looking For More Investment Ideas?

If you stop here, you risk missing companies that fit your style even better, so use the tools available and give yourself more options.

• Target potential value opportunities by scanning companies that look attractively priced relative to quality through the 47 high quality undervalued stocks.
• Strengthen your search for resilient cash generators by reviewing stocks screened for robust payouts in the 10 dividend fortresses.
• Broaden your watchlist with under-followed opportunities by checking the screener containing 22 high quality undiscovered gems that still show solid fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.